Slaughter and May advised GHO Capital on its increased investment in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organisation. As part of the transaction, Partners Group AG also acquired a significant minority stake, bringing a wealth of international healthcare expertise to the shareholder group and helping drive future value creation. Having first invested in Sterling in 2019, GHO’s increased investment, which is supported by a consortium of investors, led by funds managed by AlpInvest Partners and Pantheon, will support Sterling as it accelerates its growth plans through the expansion of production capacity across the UK, Europe and the US and to pursue additional strategic acquisitions to further expand its capabilities and geographic reach and continue to advance its strong commitment to ESG initiatives.